Picamilon

For research use only. Not for therapeutic Use.

  • CAT Number: M003727
  • CAS Number: 62936-56-5
  • Molecular Formula: C10H11N2NaO3
  • Molecular Weight: 230.199
  • Purity: ≥95%
Inquiry Now

Picamilon (CAS&nbsp;62936-56-5)<span style="color:#000000;"><span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">&nbsp;<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">is a drug formed by a synthetic combination of niacin and &gamma;-aminobutyric acid (GABA).&nbsp;</span></span></span></span><span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 14px; font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;</span><span style="color:#000000;"><span style="font-family: sans-serif; font-size: 14px; font-variant-ligatures: normal; orphans: 2; widows: 2;"><span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">It can permeate the blood-brain barrier</span></span></span><span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;"><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;and then is hydrolyzed</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;into GABA and niacin.</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;The released GABA in theory would activate GABA receptors</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;potentially producing an anxiolytic&nbsp;</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">response.</span></span></span></span>


Catalog Number M003727
CAS Number 62936-56-5
Synonyms

4-[(3-pyridinylcarbonyl)amino]-butanoic acid monosodium salt;SODIUM 4-PYRIDIN-3-YLCARBONYLAMINOBUTANOATE;SODIUM PIKAMILONE;NICOTINOYL-GABA SODIUM SALT;PICAMILON;PICAMILON SODIUM;PIKAMILONE SODIUM SALT;PIKAMILON SODIUM

Molecular Formula C10H11N2NaO3
Purity ≥95%
Storage -20°C
Overview of Clinical Research

<span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;"><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">Picamilon was developed in the Soviet Union in 1969 and further studied in both Russia and Japan as a prodrug of GABA. In Russia, &nbsp;it&nbsp;</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">is sold as a prescription drug.</span></span></span>

IUPAC Name sodium;4-(pyridine-3-carbonylamino)butanoate
InChI InChI=1S/C10H12N2O3.Na/c13-9(14)4-2-6-12-10(15)8-3-1-5-11-7-8;/h1,3,5,7H,2,4,6H2,(H,12,15)(H,13,14);/q;+1/p-1
InChIKey DGWZSECHAXUHPD-UHFFFAOYSA-M
SMILES C1=CC(=CN=C1)C(=O)NCCCC(=O)[O-].[Na+]
Reference

1: Silkina IV, Gan/&#39;shina TC, Seredin SB, Mirzoian RS. [Gabaergic mechanism of cerebrovascular and neuroprotective effects of afobazole and picamilon]. Eksp Klin Farmakol. 2005 Jan-Feb;68(1):20-4. Russian. PubMed PMID: 15786959.<br />
2: Cui W, Chen X, Zhan Y, Zhang Z, Zhang Y, Zhong D. Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 1;878(15-16):1181-4. doi: 10.1016/j.jchromb.2010.03.013. Epub 2010 Mar 16. PubMed PMID: 20359966.<br />
3: Avula B, Chittiboyina AG, Sagi S, Wang YH, Wang M, Khan IA, Cohen PA. Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States. Drug Test Anal. 2016 Mar-Apr;8(3-4):334-43. doi: 10.1002/dta.1853. Epub 2015 Oct 1. PubMed PMID: 26426301.<br />
4: Bugaeva LI, Spasov AA, Verovskiĭ VE, Iezhitsa IN. [Preclinical prognosis of pyracetam and picamilon safety based on acute toxicity data]. Eksp Klin Farmakol. 2003 Jul-Aug;66(4):43-6. Russian. PubMed PMID: 14558352.<br />
5: Likhodeev VA, Spasov AA, Isupov IB, Mandrikov VB. [Effects of aminalon, fenibut, and picamilon on the typological parameters of cerebral hemodynamics in swimmers with dysadaptation syndrome]. Eksp Klin Farmakol. 2009 Jul-Aug;72(4):15-9. Russian. PubMed PMID: 19803364.

Request a Quote